Table 1.
Study subjects characteristics by HCV status
| Characteristics |
HCV status |
|
| HCV-negative | HCV-positive | |
| Age (yr) | 46.0 (57.0) | 46.0 (51.0) |
| Genderan (%) | ||
| Male | 44 (18.4) | 195 (81.6) |
| Female | 23 (38.3) | 37 (61.7) |
| Diabetes n (%) | ||
| No | 31 (19.6) | 127 (80.4) |
| Yes | 32 (23.2) | 106 (67.8) |
| Fibrosisan (%) | ||
| No/mild | 67 (54.0) | 57 (46) |
| Moderate/severe | 0 (0.0) | 137 (100) |
| Inflammationan (%) | ||
| No/mild | 67 (100) | 0 (0.0) |
| Moderate/severe | 0 (0.0) | 194 (100) |
| Body mass index (kg/m2) | 27.9 (26.7) | 29.2 (25.3) |
| Urea (mmol/L) | 4.6 (41.4) | 4.7 (128.9) |
| Creatinine (mg/dL) | 75.0 (248.0) | 77.0 (230.0) |
| ACR (mg/mmol) | 1 (36.8) | 1 (193.9) |
| eGFR (mL/min every 1.73 m2) | 99.5 (317.0) | 98.0 (155.0) |
| Microalbuminuriaab (µg/mg) | 5.9 (299.0) | 9.5 (399.0) |
| ALTab (U/L) | 25.0 (110.0) | 66.0 (583.0) |
| Hemoglobinab (g/dL) | 14.0 (7.0) | 14.9 (9.5) |
a
P < 0.05;
b
Kruskal-Wallis test. HCV: Hepatitis C virus; ACR: Albumin creatinine ratio; eGFR: Estimated glomerular filtration rate; ALT: Alanine aminotransferase. Quantities given as median (range).